Literature DB >> 11695358

Enzymatic activity, protein expression, and gene sequence of cruzipain in virulent and attenuated Trypanosoma cruzi strains.

V G Duschak1, M Ciaccio, J R Nassert, M A Basombrio.   

Abstract

Protein expression, characterized in Western blots and gelatinolytic activity, of cruzipain (Cr), the major Trypanosoma cruzi cysteine proteinase, was compared among 3 attenuated T. cruzi strains (TUL 0, TCC, and Y null) and their virulent counterparts (TUL 2, Tulahuen, and Y). All attenuated strains displayed a weaker gelatinolytic activity as compared with their virulent counterparts. The electrophoretic mobility and immunological reactivity revealed quantitative and qualitative differences, with the attenuated parasites showing bands of less density in all strains and lower mobility in 2 of them, as compared with the virulent strains. Sequence analysis of 1 Cr gene in the Tulahuen and TCC strains indicated 37/1404 base pair substitutions, corresponding to 20 amino acid changes in the attenuated strain. A similar comparative analysis of 1 Cr gene between Y and Y null strains showed 13/1404 base pair substitutions, corresponding to 8 amino acid changes in the attenuated strain. Although enough variability exists in the Cr gene to allow for less- or nonfunctional isoforms of the protein, further clones should be analyzed to establish whether attenuation is regularly associated with specific sequence changes of this enzyme.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11695358     DOI: 10.1645/0022-3395(2001)087[1016:EAPEAG]2.0.CO;2

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  6 in total

1.  Involvement of sulfates from cruzipain, a major antigen of Trypanosoma cruzi, in the interaction with immunomodulatory molecule Siglec-E.

Authors:  Maximiliano R Ferrero; Anja M Heins; Luciana L Soprano; Diana M Acosta; Mónica I Esteva; Thomas Jacobs; Vilma G Duschak
Journal:  Med Microbiol Immunol       Date:  2015-06-06       Impact factor: 3.402

2.  Investigation of the binding mode of a novel cruzain inhibitor by docking, molecular dynamics, ab initio and MM/PBSA calculations.

Authors:  Luan Carvalho Martins; Pedro Henrique Monteiro Torres; Renata Barbosa de Oliveira; Pedro Geraldo Pascutti; Elio A Cino; Rafaela Salgado Ferreira
Journal:  J Comput Aided Mol Des       Date:  2018-03-21       Impact factor: 3.686

3.  Differentiation of Trypanosoma cruzi I (TcI) and T. cruzi II (TcII) genotypes using genes encoding serine carboxypeptidases.

Authors:  Catarina Andréa Chaves de Araújo; Christoph Mayer; Peter Josef Waniek; Patricia Azambuja; Ana Maria Jansen
Journal:  Parasitol Res       Date:  2016-07-28       Impact factor: 2.289

4.  Cruzipain promotes Trypanosoma cruzi adhesion to Rhodnius prolixus midgut.

Authors:  Lívia Almeida Uehara; Otacílio C Moreira; Ana Carolina Oliveira; Patrícia Azambuja; Ana Paula Cabral Araujo Lima; Constança Britto; André Luis Souza dos Santos; Marta Helena Branquinha; Claudia Masini d'Avila-Levy
Journal:  PLoS Negl Trop Dis       Date:  2012-12-13

5.  The Trypanosoma cruzi protease cruzain mediates immune evasion.

Authors:  Patricia S Doyle; Yuan M Zhou; Ivy Hsieh; Doron C Greenbaum; James H McKerrow; Juan C Engel
Journal:  PLoS Pathog       Date:  2011-09-01       Impact factor: 6.823

6.  Cruzipain Sulfotopes-Specific Antibodies Generate Cardiac Tissue Abnormalities and Favor Trypanosoma cruzi Infection in the BALB/c Mice Model of Experimental Chagas Disease.

Authors:  Luciana L Soprano; Maximiliano R Ferrero; Malena Landoni; Gabriela A García; Mónica I Esteva; Alicia S Couto; Vilma G Duschak
Journal:  Front Cell Infect Microbiol       Date:  2022-01-04       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.